Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (19 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 14 Dec 2018 – 20 Aug 2026, limited by SBI Nifty 200 Quality 30 ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | SBI Nifty 200 Quality 30 ETF | Nifty 500 |
|---|---|---|
| 14 Dec 2018 | ₹100.00 | ₹100.00 |
| 05 Aug 2019 | ₹94.36 | ₹97.15 |
| 26 Mar 2020 | ₹83.66 | ₹76.93 |
| 15 Nov 2020 | ₹117.01 | ₹114.25 |
| 06 Jul 2021 | ₹144.88 | ₹149.31 |
| 25 Feb 2022 | ₹150.49 | ₹156.05 |
| 17 Oct 2022 | ₹156.60 | ₹163.96 |
| 08 Jun 2023 | ₹168.08 | ₹175.12 |
| 28 Jan 2024 | ₹202.94 | ₹213.31 |
| 18 Sep 2024 | ₹257.05 | ₹262.87 |
| 09 May 2025 | ₹219.71 | ₹238.42 |
| 29 Dec 2025 | ₹241.58 | ₹260.49 |
| 20 Aug 2026 | ₹236.08 | ₹258.63 |
| Metric | SBI · Regular · IDCW NAV ₹225.69 Very High risk ★★★☆☆ | Category median Other ETFs · 19 funds |
|---|---|---|
| +0.77% | +0.77% | |
| +10.51% | +9.55% | |
| +9.01% | +9.21% | |
| — | +11.55% | |
| +11.83% | +10.84% | |
| +8.49% | — | |
| +15.27% | +13.03% | |
| +15.64% | +13.13% | |
| — | +12.79% | |
| Risk | ||
| 13.30% | 13.68% | |
| 0.30 | 0.22 | |
| 0.42 | 0.31 | |
| -29.13% | -21.96% | |
| Nifty 500 | — | |
| -0.89% | +0.04% | |
| 0.97 | 0.99 | |
| 91.1% | 99.9% | |
| 93.0% | 95.5% | |
| 0.35% | 0.25% | |
| ₹77.96Cr | ₹77.96Cr | |
| None | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Raviprakash Sharma | — | |
| 14 Dec 2018 | — | |
| 30 | — | |
| 46.5% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.